IBD: Leveraging Novel Targeted Therapies for Optimized Clinical Outcomes

IBD: Leveraging Novel Targeted Therapies for Optimized Clinical Outcomes

A satellite symposium held in conjunction with the 2017 Advances in Inflammatory Bowel Diseases: Multidisciplinary Approaches to IBD Patient-Centered Care conference.

Friday, November 10, 2017
Northern Hemisphere Ballroom, C-D
6:15 am – 7:40 am
Support by: Celgene Corporation

REGISTER NOW

 

Chair

Bruce E. Sands, MD, MS, FACG
Icahn School of Medicine at Mount Sinai
New York, New York

Faculty

Gary R. Lichtenstein, MD, FACG
University of Pennsylvania
Philadelphia, Pennsylvania

William J. Sandborn, MD, FACG
University of California San Diego
San Diego, California

Agenda

6:15 am

Breakfast and Registration

6:40 am

Welcome, introduction, pre-session knowledge, and demographic polling
Bruce E. Sands, MD, MS, FACG

6:45 am

Treat to target in IBD: Where do we stand today
Gary R. Lichtenstein, MD, FACG

7:00 am

The evolution of IBD care: Role of emerging players
William J. Sandborn, MD, FACG

7:15 am

Learning from the UC patient: Advancing patient-centric IBD care for Improving clinical outcomes in IBD
Bruce E. Sands, MD, MS, FACG

7:25 am

Learning from the CD Patient: Advancing patient-centric IBD care for improving clinical outcomes in IBD
Bruce E. Sands, MD, MS, FACG

7:35 am

Recap of key points and post-session knowledge/competence polling

7:40 am

Adjournment

Accreditation

ACCMEImedex is accredited by the Accreditation Council for Continuing Medical Education (ACCME®) to provide continuing medical education for physicians.

Imedex designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Who Should Attend

This live activity is designed to meet the educational needs of Physicians, surgeons, nurse practitioners, pharmacists, physician assistants, nurses, and other healthcare professionals who are involved and/or interested in the treatment of patients with IBD.

Learning Objectives

After successful completion of this symposium, participants should be able to:

  • Utilize current treatment goals and ‘treat-to-target’ guidelines for optimal IBD management
  • Implement the rational use of novel IBD targeted therapies in routine clinical practice
  • Understand the safety-efficacy profiles and MOA of emerging targeted therapies in IBD
Support

The following company has provided an educational grant in support of this symposium: Celgene Corporation.

Registration

Registration Fees
Registration is complimentary to those registered to attend the Advances in Inflammatory Bowel Diseases: Multidisciplinary Approaches to IBD Patient-Centered Care conference.

Available seating will be based on room capacity. Seating is limited and pre-registration is for planning purposes only and does not guarantee admission, as the room may be overbooked. Early arrival is recommended and seating will be first-come first-serve until capacity is met.

Location

Conference Location and Hotel Accommodations
Walt Disney World Dolphin Hotel
1500 Epcot Resorts Boulevard
Lake Buena Vista, Florida 32838
Tel.: +1 (407) 934 4000
http://www.swandolphin.com/home.html

The Registration and Information Desk at the Norther Hemisphere Foyer will be staffed:
Friday, November 10, 2017…………………………6:00 am – 8:00 am

Symposium Organizer

Imedex
11675 Rainwater Drive, Suite 600
Alpharetta, GA 30009, USA
Tel.: +1 (770) 751 7332
Fax: +1 (770) 751 7334
Email: meetings@imedex.com
Web: www.imedex.com
FacebookTwitterLinkedInEmail